Lessons from the deep study of rare tumours

Journal of Pathology

Volumn 224, Issue 3, 2011, Pages 306-308

  Thomas, David M ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

chondrosarcoma; metabolism; mutations; sarcoma

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ISOCITRATE DEHYDROGENASE; ONCOPROTEIN; TUMOR MARKER;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CARTILAGE TUMOR; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MOLECULAR PATHOLOGY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RARE DISEASE; RARE TUMOR; SEQUENCE ANALYSIS; TREATMENT RESPONSE;

CELL TRANSFORMATION, NEOPLASTIC; CHONDROSARCOMA; HUMANS; ISOCITRATE DEHYDROGENASE; MUTATION; RARE DISEASES; SARCOMA;

EID: 79958239179     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2928     Document Type: Article

References (13)

1. Wood LD, Parsons DW, Jones S, et al., The genomic landscapes of human breast and colorectal cancers. Science 2007; 318: 1108-1113. (Pubitemid 350134889)
2. Brown CJ, Lain S, Verma CS, et al., Awakening guardian angels: drugging the p53 pathway. Nat Rev Cancer 2009; 9: 862-873.
3. Toledo F, Wahl GM,. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6: 909-923. (Pubitemid 44862676)
4. Pierotti MA, Tamborini E, Negri T, et al., Targeted therapy in GIST: in silico modeling for prediction of resistance. Nat Rev Clin Oncol; 8: 161-170.
5. Amary FM, Bacsi K, Maggiani F, et al., IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondroms but not in other mesenchymal tumors. J Pathol 2011; 224: 334-343.
6. Parsons DW, Jones S, Zhang X, et al., An integrated genomic analysis of human glioblastoma multiforme. Science 2008; 321: 1807-1812.
7. Warburg O,. On respiratory impairment in cancer cells. Science 1956; 124: 269-270.
8. Plas DR, Thompson CB,. Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab 2002; 13: 75-78.
9. Klionsky DJ,. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007; 8: 931-937. (Pubitemid 47622558)
10. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell; 144: 646-674.
11. McWhinney SR, Pasini B, Stratakis CA,. Familial gastrointestinal stromal tumors and germline mutations. N Engl J Med 2007; 357: 1054-1056. (Pubitemid 47367102)
12. Figueroa ME, Abdel-Wahab O, Lu C, et al., Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function and impair hematopoietic differentiation. Cancer Cell; 18: 553-567.
13. Santos FP, Kantarjian H, Garcia-Manero G, et al., Decitabine in the treatment of myelodysplastic syndromes. Expert Rev Anticancer Ther; 10: 9-22.